Cargando…
Acute exacerbation of chronic bronchitis: disease-specific issues that influence the cost-effectiveness of antimicrobial therapy
Background: Acute exacerbation of chronic bronchitis (AECB) is a common condition, with substantial associated costs and morbidity. Research efforts have focused on innovations that will reduce the morbidity associated with AECB. Health care payers increasingly expect that the results of evidence-ba...
Autores principales: | Saint, Sanjay, Flaherty, Kevin R., Abrahamse, Paul, Martinez, Fernando J., Fendrick, A.Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133766/ https://www.ncbi.nlm.nih.gov/pubmed/11318083 http://dx.doi.org/10.1016/S0149-2918(01)80053-9 |
Ejemplares similares
-
Antibacterials and Acute Exacerbation of Chronic Bronchitis: Issues for Formulary Decision Makers
por: Chock, Alan, et al.
Publicado: (2012) -
Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD
por: Miravitlles, Marc
Publicado: (2007) -
Epidemiology and Treatment of Chronic Bronchitis and Its Exacerbations
por: Ball, Peter
Publicado: (1995) -
Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
por: Cazzola, Mario, et al.
Publicado: (2015) -
Respiratory illness caused by picornavirus infection: a review of clinical outcomes
por: Monto, Arnold S., et al.
Publicado: (2001)